Stay updated on CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial

Sign up to get notified when there's something new on the CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page now shows a new revision number, v3.6.2, replacing the previous v3.6.0. This indicates an internal update to the page rendering without changing the study information displayed.
    Difference
    0.0%
    Check dated 2026-06-28T08:53:43.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The page now includes new user-focused sections and links such as Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, and How to Join a Study, with recent revision markers (2026-06-10 and 2026-06-09) and a v3.6.0 update. Older sections like Intervention / Treatment and NCI Pediatric Leukemia, Lymphoma Transpl were removed, indicating a reorganization of participation and treatment details.
    Difference
    0.5%
    Check dated 2026-06-14T05:11:48.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    A new revision label v3.5.5 was added to the page, indicating a minor platform update rather than substantive changes to the study details.
    Difference
    0.0%
    Check dated 2026-06-07T02:08:51.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The study title and description were updated to reflect a new, more detailed Phase I/II CD19/CD22-CAR T cell trial in children and young adults with B cell malignancies. The update adds phase-specific design elements, dosing cohorts, and eligibility details, while older wording was removed or superseded to align with the new structure.
    Difference
    3%
    Check dated 2026-05-30T23:26:35.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The page shows Revision: v3.5.4, indicating a new release of the page template. This metadata update does not modify study details, eligibility criteria, or contact information.
    Difference
    0.0%
    Check dated 2026-05-16T09:22:40.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    ClinicalTrials.gov’s page footer now shows a newer software/revision version (v3.5.3 instead of v3.5.2) for the site build, without impacting the study content.
    Difference
    0.0%
    Check dated 2026-04-24T22:18:06.000Z thumbnail image

Stay in the know with updates to CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial page.